Accessibility Menu
 
Feedback Plc logo

Feedback Plc

(LSE) FDBK

Current Price$12.50
Market Cap$552.07M
Since IPO (1992)-100%
5 Year-95%
1 Year-20%
1 Month-5%

Feedback Plc Financials at a Glance

Market Cap

$552.07M

Revenue (TTM)

$2.04M

Net Income (TTM)

$10.42M

EPS (TTM)

$-16.39

P/E Ratio

-0.77

Dividend

$0.00

Beta (Volatility)

-0.13 (Low)

Price

$12.50

Volume

22,188

Open

$12.50

Previous Close

$12.50

Daily Range

$12.20 - $12.50

52-Week Range

$7.50 - $17.70

FDBK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Feedback Plc

Industry

Health Care Technology

Employees

29

CEO

Thomas James Oakley, MD

Website

fbkmed.com

Headquarters

London, EC4Y 0DT, GB

FDBK Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

-5%

Net Income Margin

-8%

Return on Equity

-90%

Return on Capital

-92%

Return on Assets

-1%

Earnings Yield

-1.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$552.07M

Shares Outstanding

43.81M

Volume

22.19K

Short Interest

0.00%

Avg. Volume

98.80K

Financials (TTM)

Gross Profit

$778.65K

Operating Income

$4.21M

EBITDA

$4.19M

Operating Cash Flow

$2.82M

Capital Expenditure

$10.45K

Free Cash Flow

$2.83M

Cash & ST Invst.

$5.95M

Total Debt

$0.00

Feedback Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$413.00K

-5.5%

Gross Profit

$157.00K

-60.8%

Gross Margin

38.01%

N/A

Market Cap

$552.07M

N/A

Market Cap/Employee

$20.45M

N/A

Employees

27

N/A

Net Income

$1.74M

+10.0%

EBITDA

$1.70M

-4.5%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$3.82M

-28.8%

Accounts Receivable

$312.00K

-46.8%

Inventory

$0.00

+100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.48%

N/A

Return on Invested Capital

-91.96%

N/A

Free Cash Flow

$1.80M

-34.5%

Operating Cash Flow

$1.80M

-34.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GDR.LGenedrive Plc
$0.95+0.00%
TRX.LTissue Regenix Group plc
$7.25+0.00%
MHC.LMyHealthChecked PLC
$8.75-2.78%
CRTX.LCRISM Therapeutics Corporation
$11.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%

Questions About FDBK

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.